StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Edwards Lifesciences (EW) Raising Estimates, PT on Better Than Expected Sapien 3 Data - Leerink Partners
April 4, 2016 7:50 AM
Leerink Partners analyst, Danielle Antalffy, raised her PT on Edwards Lifesciences by nearly 25% to $115 to account for better ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst EPS Change
Analyst PT Change
Next Articles
Northland Capital Markets Downgrades Edwards Lifesciences (EW) to Market Perform (Earlier)
April 5, 2016 10:27 AM
Stifel Raises Price Target on Edwards Lifesciences (EW) to $117; Reiterates Buy
April 4, 2016 10:33 AM
BTIG Upgrades Edwards Lifesciences (EW) to Buy
April 4, 2016 7:35 AM
Edwards Lifesciences (EW) PT Raised to $98 at Credit Suisse Following Sapien Data
April 4, 2016 7:21 AM
Edwards Lifesciences (EW) PT Raised to at Jefferies Following PARTNER II Sapien 3 Data
April 4, 2016 6:45 AM
Edwards Lifesciences' (EW) SAPIEN XT PARTNER II Trial Met Primary Endpoint
April 3, 2016 12:20 PM
Edwards Lifesciences (EW) Announces Strong SAPIEN 3 TAVR Data vs. Surgery
April 3, 2016 12:19 PM
